Episode 455: Photobiomodulation Discussion with Dr. David Boyer

Dr. David Boyer joins the podcast to discuss the Lumithera Valeda (photobiomodulation) FDA approval and what it means for retina specialists and patients.

Relevant Financial Disclosures: Dr. Boyer received research funding as a clinical trial site for Lumithera.

You can claim CME credits for prior episodes via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=Audi